search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Supply chain & logistics


Strong partnerships and smart planning keep pharma air cargo moving safely through complex challenges.


CEIV Pharma, which is now accessible for SMEs as well as major carriers, helps the industry to address the need for high-quality services, expertise, infrastructure, facilities and regulatory awareness. Developed with key aviation industry stakeholders and regulators, it is designed to help everyone involved in the air cargo supply chain to develop better safety, security, compliance and efficiency through a globally consistent and recognised pharmaceutical-product handling certification. IATA’s work to develop CEIV Pharma illustrates another key component in supply chain resilience, namely the ability of multiple stakeholders to collaborate around a shared goal. Collaborative planning, joint risk assessments and shared forecasting all help to coordinate responses, especially if IoT sensors and other tracking systems are generating good-quality data by monitoring shipments in real time. By sharing resources, expertise, and technology, partnerships engender better communication and coordination between all stakeholders, keeping everyone aligned and able to respond quickly to disruptions. IATA itself plays a crucial role in developing strong collaborative working arrangements to manage air freight disruptions effectively. It develops and promotes industry-wide standards for handling pharmaceutical products, ensuring consistency and reliability across the supply chain, and shares best practices to help companies adopt effective strategies for managing disruptions. The IATA Healthcare Cargo Working Group (HCWG) brings together airlines, logistics providers, and pharmaceutical companies to address common challenges and develop joint solutions, and there are specialised training programmes designed and developed by professionals with more than 30 years of experience in air cargo pharma logistics.


34


The HCWG’s work to enhance the reliability of the pharmaceutical supply chain is ongoing and includes recommendations to the Live Animals and Perishables Board (LAPB) on the development of healthcare cargo transportation and handling standards to ensure that pharma products are transported under optimal conditions. It also contributes to the IATA Temperature Control Regulations, which are designed to address temperature management issues raised by the pharma industry. They include the compulsory use of the Time and Temperature Sensitive Label to ensure that shipments are handled according to their specific temperature requirements. Furthermore, the HCWG collaborates with leading authorities to create guidance documents for the transportation and distribution of healthcare products, complete with detailed considerations for handling large-scale shipments, such as vaccines, ensuring preparedness and compliance with regulatory requirements.


“The HCWG supports the development of training programmes and educational resources to enhance the skills of personnel involved in the pharmaceutical supply chain,” adds Ben Hamida. “This ensures stakeholders are knowledgeable about best practices and regulatory requirements. It also regularly reviews and updates standards to ensure they remain relevant and effective in addressing the evolving needs of the pharmaceutical supply chain.” Among the most important considerations for managing air freight disruptions are supplier diversification, technological integration, risk monitoring and contingency planning to ensure flexibility and agility. Yet perhaps nothing is more important than collaboration between all stakeholders – from airlines and their customers to regulators – to focus on the bigger picture. ●


World Pharmaceutical Frontiers / www.worldpharmaceuticals.net


BeAvPhoto/Shutterstock.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58